McKesson Corporation (MCK), Cerner Corporation (CERN), athenahealth, Inc (ATHN): These High-Flying Stocks Could Be Riskier Than You Think

Page 1 of 2

Health care technology has been hot over the past few years. Billions of taxpayer dollars were spent to encourage hospitals and physicians to use electronic health record, or EHR, systems. These incentives translated to higher sales and profits for the vendors of those systems.

Boatloads of federal money injected into health care continues to bolster the stocks of EHR companies. Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) shares have soared by 68% year-to-date. athenahealth, Inc (NASDAQ:ATHN) is up 54%. Quality Systems, Inc. (NASDAQ:QSII)‘ stock has gained more than 30% this year. Large players Cerner Corporation (NASDAQ:CERN) and McKesson Corporation (NYSE:MCK) are both up around 27%.

But could these high-flying stocks actually be riskier than they might appear at first glance? A couple of recent reports suggest the answer might be “yes.”

Not so hot
A study published in the Annals of Internal Medicine found that use of EHR systems didn’t lower inpatient costs. Savings were seen in ambulatory settings — but costs decreased by only 3.4% per year after using EHR technology for 18 months. At that rate, according to the study, it would take seven years for health care providers to recover their investment.

Physicians don’t think EHR systems are saving them any money. Actually, they think the opposite is true. The 2013 Physician Outlook survey recently conducted by market research firm Ipsos for Wolters Kluwer Health found that 68% of physicians said that their costs are going up. The top reasons cited for higher costs were implementation of health information technology, Obamacare and other government regulation, and uninsured patients.

Another study published in the March issue of Health Affairs appears to confirm the survey findings. Researchers found that only 27% of physicians have a positive return-on-investment within five years from implementing EHR systems. Even with federal incentives thrown in, only 41% would make their investment back in five years.

If health care providers face losing investments even with Uncle Sam’s help, why would they spend money to buy EHR systems? The risk for vendors like the high-flyers mentioned earlier is that many providers will decide that EHR technology isn’t as hot as it has been cracked up to be.

Still warming up
On the other hand, a major reason why health care providers aren’t seeing better returns should be easily addressed. Researchers found that a large number of physician practices, for example, experienced negative financial returns because they didn’t make operational challenges such as discontinuing use of paper medical records.

And many of the physicians surveyed by Ipsos see benefits in using EHR systems. 55% of respondents think that health information technology can help improve patient safety. 51% said that EHR systems can help improve evidence-based care.

Even if health care providers that haven’t jumped on the EHR bandwagon opt out, solid market potential exists for capturing market share from dissatisfied customers that already use EHR technology. Around 23% of physicians have said they planned to switch to a new system this year.

McKesson Corporation (NYSE:MCK)Credit: McKesson Corporation (NYSE:MCK)

Several of our high-flying EHR companies have impressed customers enough to attract other customers who weren’t so happy with their previous systems. A new Black Book Rankings report found that physicians who switched to a new EHR system are moving to a handful of vendors, including athenahealth, Inc (NASDAQ:ATHN) and Cerner Corporation (NASDAQ:CERN). Allscripts, McKesson Corporation (NYSE:MCK), and Quality Systems, Inc. (NASDAQ:QSII)’s NextGen also received top rankings in client experience surveys conducted by Black Book.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!